Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration

被引：0
|
作者：
Bommakanti, Nikhil
Young, Benjamin K.
Sisk, Robert A.
Berrocal, Audina M.
Duncan, Jacque L.
Bakall, Benjamin
Mathias, Marc T.
Ahmed, Ishrat
Chorfi, Sarah
Comander, Jason
Nagiel, Aaron
Besirli, Cagri G.
机构：
来源：
OPHTHALMOLOGY | 2024年 / 131卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：130 / 130
页数：1
相关论文
共 47 条
  • [21] Chorioretinal Atrophy Growth After Voretigene Neparvovec Retinotopically Is Connected to Retinal Functional Rescue
    Stingl, Krunoslav
    Kempf, Melanie
    Jung, Ronja
    Stingl, Katarina
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (02):
  • [22] Is chorioretinal atrophy after voretigene neparvovec connected to the local retinal rod rescue?
    Stingl, Katarina
    Kempf, Melanie
    Stingl, Krunoslav
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] Year 2 results for a phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease
    Russell, Stephen R.
    Bennett, Jean
    Wellman, Jennifer A.
    Chung, Daniel C.
    High, Katherine A.
    Yu, Zi-Fan
    Tillman, Amy
    Maguire, Albert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [24] Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl
    Amato, A.
    Tschetter, W.
    Everett, L.
    Bailey, S. T.
    Lauer, A. K.
    Yang, P.
    Pennesi, M. E.
    DOCUMENTA OPHTHALMOLOGICA, 2024, 149 (02) : 63 - 75
  • [25] Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease Phase 3 Results at 3 and 4 Years
    Maguire, Albert M.
    Russell, Stephen
    Chung, Daniel C.
    Yu, Zi-Fan
    Tillman, Amy
    Drack, Arlene V.
    Simonelli, Francesca
    Leroy, Bart P.
    Reape, Kathleen Z.
    High, Katherine A.
    Bennett, Jean
    OPHTHALMOLOGY, 2021, 128 (10) : 1460 - 1468
  • [26] A COST-EFFECTIVENESS ANALYSIS OF VORETIGENE NEPARVOVEC FOR VISION LOSS DUE TO BIALLELIC RPE65-MEDIATED INHERITED RETINAL DISEASE
    Zimmermann, M. R.
    Lubinga, S. J.
    Rind, D.
    Chapman, R. H.
    Carlson, J. J.
    VALUE IN HEALTH, 2018, 21 : S205 - S206
  • [27] Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy Results of Phase 1 and 3 Trials
    Maguire, Albert M.
    Russell, Stephen
    Wellman, Jennifer A.
    Chung, Daniel C.
    Yu, Zi-Fan
    Tillman, Amy
    Wittes, Janet
    Pappas, Julie
    Elci, Okan
    Marshall, Kathleen A.
    McCague, Sarah
    Reichert, Hannah
    Davis, Maria
    Simonelli, Francesca
    Leroy, Bart P.
    Wright, J. Fraser
    High, Katherine A.
    Bennett, Jean
    OPHTHALMOLOGY, 2019, 126 (09) : 1273 - 1285
  • [28] COST-EFFECTIVENESS OF VORETIGENE NEPARVOVEC FOR VISION LOSS DUE TO BIALLELIC RPE65-MEDIATED INHERITED RETINAL DISEASE IN A DANISH SETTING
    Ploug, U.
    VALUE IN HEALTH, 2019, 22 : S846 - S846
  • [29] Functional outcomes and adverse effects of voretigene neparvovec for biallelic RPE65-mediated inherited retinal dystrophies in a cohort of patients from a single centre
    Kiraly, Peter
    Cottriall, Charles
    Taylor, Laura J.
    Jolly, Jasleen K.
    Cehajic-Kapetanovic, Jasmina
    Yusuf, Imran H.
    dela Camara, Cristina Martinez-Fernandez
    Shanks, Morag
    Downes, Susan M.
    MacLaren, Robert E.
    Fischer, Dominik M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [30] Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center
    Kiraly, Peter
    Cottriall, Charles L.
    Taylor, Laura J.
    Jolly, Jasleen K.
    Cehajic-Kapetanovic, Jasmina
    Yusuf, Imran H.
    de la Camara, Cristina Martinez-Fernandez
    Shanks, Morag
    Downes, Susan M.
    MacLaren, Robert E.
    Fischer, M. Dominik
    BIOMOLECULES, 2023, 13 (10)
12345